Skip to content

Assessment of cardiac function and multifactorial intervention in patients with type 2 diabetes and carotid artery atherosclerosis

Assessment of cardiac function and multifactorial intervention in patients with type 2 diabetes and carotid artery atherosclerosis

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001230
Enrollment
Unknown
Registered
2009-08-10
Start date
2009-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes with carotid artery atherosclerosis

Interventions

treated group A:HBA1c>7%+other risk factors intervention+detection of SPECT
control group a:HBA1c>7%+other risk factors intervention
treated group B:HBA1c7%+other risk factors intervention
treated group D:HBA1c>7%+other risk factors intervention

Sponsors

Southwest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 45 to 80 years old; 2. Diagnosis of type 2 diabetes mellitus according to the WHO(1999) criteria and stable diabetes therapy for at 3 months; 3. CIMT >=1 mm or exist plaque(diameter>=1mm); 4. Ability to perform all tasks related to glycemic control and risk-factor management and accepted detection of myocardial function and informed written consent.

Exclusion criteria

Exclusion criteria: 1. Hepatic and renal disease (serum creatinine >=1.2 times the upper limit of normal,alanine aminotransferase >=2 times the upper limit of normal); 2. Existed ketosis or etoacidosis or hyperosmolar nonketotic diabetic coma or gross stress reaction in the past half a year; 3. Pregnant or lactating women; 4. History of mental aberration; 5. Hemorrhagic tendency; 6. Noncardiac illness expected to limit survival; 7. Current alcohol abuse; 8. Enrolled in a competing randomized trial or clinical study in the past 4weeks; 9. Geographically inaccessible or unable to return for follow-up; 10. Unable to understand or cooperate with protocol requirements.

Design outcomes

Primary

MeasureTime frame
cardiovascular end point events;

Secondary

MeasureTime frame
biochemical indices of lipid;coronary arteriongraphy;biochemical indices of glucose;biochemical indices of hypertension;

Countries

China

Contacts

Public ContactBing Chen
chenbing3@medmail.com.cn+86 1399653631

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026